Top Markets
#1 Pleasing Gold Pleasing Gold +1,500.96%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +35.79%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.74%
#5 BOOK OF MEME BOOK OF MEME +30.32%
#6 ConstitutionDAO ConstitutionDAO +27.37%
#7 Collect on Fanable Collect on Fanable +24.65%
#8 Unit Pump Unit Pump +23.57%
#9 Neiro Neiro +22.56%
#10 Pump.fun Pump.fun +22.12%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Rank in Stocks #26669
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Share Price
$5.54
Last synced: 2024-09-18
Market Cap
$38.76M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Alimera Sciences, Inc. (ALIM)

Category

Healthcare
Number of shares outstanding for Alimera Sciences, Inc. (ALIM)
Number of shares outstanding as of June 2024: 54.38M
According to Alimera Sciences, Inc. latest financial reports and stock price the company's current number of shares outstanding is 54.38M. At the end of December 2022 the company had 7.00M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Alimera Sciences, Inc. (ALIM) from 2006 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 54.38M 112.75%
2023 25.56M 265.33%
2022 7.00M 6.10%
2021 6.60M 28.86%
2020 5.12M 7.30%
2019 4.77M -18.70%
2018 5.87M 31.37%
2017 4.47M 26.88%
2016 3.52M 18.80%
2015 2.96M 10.03%
2014 2.69M 27.93%
2013 2.11M 0.38%
2012 2.10M 0.29%
2011 2.09M 0.29%
2010 2.09M 1,961.13%
2009 101.16K -6.28%
2008 107.93K 0.00%
2007 107.93K 0.00%
2006 107.93K 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 2.40B 4,311.84%
IN